1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
2 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2023 | |
|---|---|---|
| Revenue | 0 | 100.00% |
| Gross profit | 0 | 100.00% |
| Net profit | -6.8M | 359.14% |
| EBITDA | -15.67M | 410.02% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €221.38K |
Number of shares | 512.99K |
52-week high/low | €451.58 - €0.069 |
| Dividends | No |
Beta | 0.01 |
P/E ratio | 0.00 |
PEG ratio | 0.00 |
P/B ratio | 0.00 |
P/S ratio | 0.00 |
Company profile
| Name | TC BioPharm ADR |
| CEO | Bryan Leland Kobel |
| Employees | 41 |
Discover assets
Shareholders of TC BioPharm ADR also invest in the following assets
